论文部分内容阅读
肝细胞癌(hepatocellular carcinoma,HCC)是最常见的恶性肿瘤之一,其预后往往不好,严重危害人类身体健康。经导管肝动脉化疗栓塞(transcatheter arterial chemoembolization,TA-CE)已成为HCC患者姑息性治疗首选的治疗方法。因HCC的肿瘤生物学特性,HCC TACE术后复发的潜在可能性
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors, and its prognosis is often poor, which seriously endangers human health. Transcatheter arterial chemoembolization (TA-CE) has become the preferred treatment for palliative treatment in patients with HCC. Potential for recurrence after HCC TACE due to tumor biology of HCC